COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Jun 24

PMID 35741313

Authors

Debashis Dutta

Sarah Naiyer

Sabanaz Mansuri

Neeraj Soni

Vandana Singh

Khalid Hussain Bhat

Nishant Singh

Gunjan Arora

M Shahid Mansuri

Affiliations

Soon will be listed here.

Abstract

The world is grappling with the coronavirus disease 2019 (COVID-19) pandemic, the causative agent of which is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 symptoms are similar to the common cold, including fever, sore throat, cough, muscle and chest pain, brain fog, dyspnoea, anosmia, ageusia, and headache. The manifestation of the disease can vary from being asymptomatic to severe life-threatening conditions warranting hospitalization and ventilation support. Furthermore, the emergence of mutecated variants of concern (VOCs) is paramount to the devastating effect of the pandemic. This highly contagious virus and its emergent variants challenge the available advanced viral diagnostic methods for high-accuracy testing with faster result yields. This review is to shed light on the natural history, pathology, molecular biology, and efficient diagnostic methods of COVID-19, detecting SARS-CoV-2 in collected samples. We reviewed the gold standard RT-qPCR method for COVID-19 diagnosis to confer a better understanding and application to combat the COVID-19 pandemic. This comprehensive review may further develop awareness about the management of the COVID-19 pandemic.

Citing Articles

Fluorogenic oligonucleotide cleavage probes with a branched linker improve RNA detection.

Maru B, Edinboro A, Katolik A, El-Khoury R, Basran K, Wahba A Nucleic Acids Res. 2025; 53(5).

PMID: 40052819 PMC: 11886808. DOI: 10.1093/nar/gkaf141.

Subgenomic RNA Detection in SARS-CoV-2 Assessing Replication and Inactivation Through Serial Passages, RT-qPCR, and Electron Microscopy.

Franca T, da Silva J, da Silva G, Dos Santos B, Silva S, Linhares J Int J Mol Sci. 2025; 26(3).

PMID: 39941049 PMC: 11818844. DOI: 10.3390/ijms26031281.

Pathogenic and periodontal bacteria may contribute to the fatal outcome of critically ill elderly COVID-19 patients.

Madronero L, Calvo E, Coronel-Ruiz C, Velandia-Romero M, Calderon-Pelaez M, Arturo J Sci Rep. 2025; 15(1):4490.

PMID: 39915668 PMC: 11802917. DOI: 10.1038/s41598-025-88518-y.

Loop-mediated isothermal amplification assays for the detection of antimicrobial resistance elements in Vibrio cholera.

Negron D, Trivedi S, Tolli N, Ashford D, Melton G, Guertin S BMC Bioinformatics. 2024; 25(1):384.

PMID: 39695927 PMC: 11657800. DOI: 10.1186/s12859-024-06001-3.

Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study.

Zafilaza K, Bellet J, Truffot A, Foulongne V, Onambele M, Salmona M Viruses. 2024; 16(10).

PMID: 39459877 PMC: 11512400. DOI: 10.3390/v16101542.

References

Annavajhala M, Mohri H, Wang P, Nair M, Zucker J, Sheng Z . Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021; 597(7878):703-708. PMC: 8481122. DOI: 10.1038/s41586-021-03908-2. View

da Silva R, Marinho L, Silva D, de Lima K, Pirih F, Martins A . Saliva as a possible tool for the SARS-CoV-2 detection: A review. Travel Med Infect Dis. 2020; 38:101920. PMC: 7674016. DOI: 10.1016/j.tmaid.2020.101920. View

Nonaka C, Graf T, Barcia C, Costa V, de Oliveira J, da Hora Passos R . SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021. Int J Infect Dis. 2021; 111:47-54. PMC: 8356754. DOI: 10.1016/j.ijid.2021.08.003. View

Carroll T, Fox D, van Doremalen N, Ball E, Morris M, Sotomayor-Gonzalez A . The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters. PLoS Pathog. 2022; 18(2):e1009914. PMC: 8865701. DOI: 10.1371/journal.ppat.1009914. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

Lee E, Ng M, Khong P . COVID-19 pneumonia: what has CT taught us?. Lancet Infect Dis. 2020; 20(4):384-385. PMC: 7128449. DOI: 10.1016/S1473-3099(20)30134-1. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Woo P, Huang Y, Lau S, Yuen K . Coronavirus genomics and bioinformatics analysis. Viruses. 2011; 2(8):1804-1820. PMC: 3185738. DOI: 10.3390/v2081803. View

10.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

11.

Khan P, Aufdembrink L, Engelhart A . Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings. ACS Synth Biol. 2020; 9(11):2861-2880. DOI: 10.1021/acssynbio.0c00359. View

12.

Younes N, Al-Sadeq D, Al-Jighefee H, Younes S, Al-Jamal O, Daas H . Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020; 12(6). PMC: 7354519. DOI: 10.3390/v12060582. View

13.

Wall E, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C . Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021; 397(10292):2331-2333. PMC: 8175044. DOI: 10.1016/S0140-6736(21)01290-3. View

14.

Hung L . The SARS epidemic in Hong Kong: what lessons have we learned?. J R Soc Med. 2003; 96(8):374-8. PMC: 539564. DOI: 10.1177/014107680309600803. View

15.

Yang W, Greene S, Peterson E, Li W, Mathes R, Graf L . Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant. Sci Adv. 2022; 8(4):eabm0300. PMC: 8797779. DOI: 10.1126/sciadv.abm0300. View

16.

Tajadini M, Panjehpour M, Javanmard S . Comparison of SYBR Green and TaqMan methods in quantitative real-time polymerase chain reaction analysis of four adenosine receptor subtypes. Adv Biomed Res. 2014; 3:85. PMC: 3988599. DOI: 10.4103/2277-9175.127998. View

17.

McCallum M, Bassi J, De Marco A, Chen A, Walls A, di Iulio J . SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021; 373(6555):648-654. PMC: 9835956. DOI: 10.1126/science.abi7994. View

18.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

19.

van Kasteren P, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A . Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol. 2020; 128:104412. PMC: 7206434. DOI: 10.1016/j.jcv.2020.104412. View

20.

Mackay I, Arden K . MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015; 12:222. PMC: 4687373. DOI: 10.1186/s12985-015-0439-5. View